Blood Specimen Collection For Laboratory Assay Research
1 other identifier
observational
10,000
1 country
1
Brief Summary
To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 16, 2023
CompletedFirst Submitted
Initial submission to the registry
September 6, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2033
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 15, 2033
November 14, 2024
November 1, 2024
10 years
September 6, 2023
November 13, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Correlation between capillary and venous samples upon collection
R-value comparing the lab readings generated by venous and capillary samples for a specific blood analyte immediately upon collection
10 years
Stability of the capillary blood sample after storage on Days 1, 2, and 3
Median error % to compare the difference in values of each capillary sample after storage for a certain period of time (e.g., Days 1, 2, and 3) for a specific analyte when compared to the lab reading generated by the venous sample immediately upon collection
10 years
Eligibility Criteria
Healthy members of the community aged 18 years and over
You may qualify if:
- Any gender, in good general health
- Must be 18 years old or older, inclusive at enrollment
- Must be willing to provide capillary blood samples via a fingerstick and venous blood samples, including self-collection and collection by a licensed healthcare professional
- Must be able to read, understand, and willingly sign an Informed Consent Form (ICF) and complete a brief health questionnaire
- Must be able to read, speak and understand English
- Must be available to attend one study visit at Investigator's laboratory or a third-party laboratory designated by the Investigator or collect samples at home, at the discretion of the Investigator.
You may not qualify if:
- Individuals who are unable to provide a blood sample due to any illness
- Individuals participating in another research study, that the Investigator feels may compromise study outcomes
- Individuals having an acute or chronic disease or medical condition, including pregnancy, which could excessively increase study risk in the opinion of the Investigator or compromise study outcomes
- Individuals who are unlikely to be available for the duration of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roman Health Ventures Study Site
San Francisco, California, 94107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nitin Vaswani, MD
Principal Investigator
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2023
First Posted
September 21, 2023
Study Start
August 16, 2023
Primary Completion (Estimated)
July 31, 2033
Study Completion (Estimated)
August 15, 2033
Last Updated
November 14, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
No IPD will be shared with other researchers